XML 47 R36.htm IDEA: XBRL DOCUMENT v3.5.0.2
SHAREHOLDERS' EQUITY (Tables)
 6 Months Ended
Jun. 30, 2016
Stockholders' Equity Note [Abstract]  
Schedule of shareholders' equity
 
Valeant Pharmaceuticals International, Inc. Shareholders
 
 
 
 
 
Common Shares
 
Additional
Paid-In
Capital
 
Accumulated
Deficit
 
Accumulated
Other
Comprehensive
Loss
 
Valeant
Pharmaceuticals
International, Inc.
Shareholders’
Equity
 
Noncontrolling
Interest
 
Total
Equity
 
Shares
(in millions)
 
Amount
 
 
 
 
 
 
Balance, January 1, 2015 (restated)
334.4

 
$
8,349.2

 
$
243.9

 
$
(2,397.8
)
 
$
(915.9
)
 
$
5,279.4

 
$
122.3

 
$
5,401.7

Issuance of common stock (see below)
7.5

 
1,481.0

 
—

 
—

 
—

 
1,481.0

 
—

 
1,481.0

Common shares issued under share-based compensation plans
1.1

 
57.0

 
(34.9
)
 
—

 
—

 
22.1

 
—

 
22.1

Repurchases of common shares
(0.2
)
 
(6.4
)
 
—

 
(43.6
)
 
—

 
(50.0
)
 
—

 
(50.0
)
Share-based compensation
—

 
—

 
60.9

 
—

 
—

 
60.9

 
—

 
60.9

Employee withholding taxes related to share-based awards
—

 
—

 
(61.5
)
 
—

 
—

 
(61.5
)
 
—

 
(61.5
)
Excess tax benefits from share-based compensation
—

 
—

 
25.6

 
—

 
—

 
25.6

 
—

 
25.6

Noncontrolling interest distributions
—

 
—

 
—

 
—

 
—

 
—

 
(1.1
)
 
(1.1
)
 
342.8

 
9,880.8

 
234.0

 
(2,441.4
)
 
(915.9
)
 
6,757.5

 
121.2

 
6,878.7

Comprehensive loss:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (restated)
—

 
—

 
—

 
44.7

 
—

 
44.7

 
2.2

 
46.9

Other comprehensive loss
—

 
—

 
—

 
—

 
(375.6
)
 
(375.6
)
 
(0.4
)
 
(376.0
)
Total comprehensive loss (restated)
 
 
 
 
 
 
 
 
 
 
(330.9
)
 
1.8

 
(329.1
)
Balance, June 30, 2015 (restated)
342.8

 
$
9,880.8

 
$
234.0

 
$
(2,396.7
)
 
$
(1,291.5
)
 
$
6,426.6

 
$
123.0

 
$
6,549.6

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, January 1, 2016
342.9

 
$
9,897.4

 
$
304.9

 
$
(2,749.7
)
 
$
(1,541.6
)
 
$
5,911.0

 
$
118.8

 
$
6,029.8

Common shares issued under share-based compensation plans
0.1

 
17.5

 
(13.0
)
 
—

 
—

 
4.5

 
—

 
4.5

Share-based compensation
—

 
—

 
97.2

 
—

 
—

 
97.2

 
—

 
97.2

Employee withholding taxes related to share-based awards
—

 
—

 
(7.3
)
 
—

 
—

 
(7.3
)
 
—

 
(7.3
)
Excess tax expense from share-based compensation
—

 
—

 
(1.4
)
 
—

 
—

 
(1.4
)
 
—

 
(1.4
)
Noncontrolling interest distributions
—

 
—

 
—

 
—

 
—

 
—

 
(9.1
)
 
(9.1
)
 
343.0

 
9,914.9

 
380.4

 
(2,749.7
)
 
(1,541.6
)
 
6,004.0

 
109.7

 
6,113.7

Comprehensive loss:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss
—

 
—

 
—

 
(676.0
)
 
—

 
(676.0
)
 
(0.9
)
 
(676.9
)
Other comprehensive loss
—

 
—

 
—

 
—

 
(32.1
)
 
(32.1
)
 
(1.6
)
 
(33.7
)
Total comprehensive loss
 
 
 
 
 
 
 
 
 
 
(708.1
)
 
(2.5
)
 
(710.6
)
Balance, June 30, 2016
343.0

 
$
9,914.9

 
$
380.4

 
$
(3,425.7
)
 
$
(1,573.7
)
 
$
5,295.9

 
$
107.2

 
$
5,403.1